ACTIVATION OF WNT AND MAPK PATHWAYS IN OESOPHAGEAL ADENOCARCINOMA AND DURING PROGRESSION OF BARRETT’S OESOPHAGUS

(1) MRC Cancer Cell Unit, Hutchison-MRC Research Centre, Cambridge

(2) Department of Surgery, Bristol Royal Infirmary, Bristol, United Kingdom

(3) Molecular Profiling, Merck Research Laboratories, North Wales, United States

(4) Cambridge Oesophago-Gastric Centre, Addenbrookes, Cambridge, United Kingdom



This item was part of the Oesophageal carcinoma session at Gastro 2009 UEGW/WCOG London (17th UEGW)

This item can be cited as: Gut 2009; 58 (Suppl II) A83

You may be interested in:

Barrett's and oesophageal cancer
English, Presentation, Oesophagus, Pancreas, 2016, Disease Mechanisms, Histopathology, Immunology, Digestive Oncology

Categorisation:

  • Format
    • Abstract
  • Language
    • English
  • Year
    • 2009